Filing Details
- Accession Number:
- 0001104659-20-081224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-06 16:15:57
- Reporting Period:
- 2020-07-02
- Accepted Time:
- 2020-07-06 16:15:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1442836 | Mersana Therapeutics Inc. | MRSN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782805 | Ashish Mandelia | C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 | Vp, Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-30 | 3,383 | $4.87 | 3,383 | No | 5 | P | Direct | |
| Common Stock | Disposition | 2020-07-02 | 3,383 | $22.49 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Issuer's 2017 Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of January 1, 2020 through June 30, 2020.
- In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock December 31, 2019.
- Transaction made pursuant to the Reporting Person's company-approved trading plan under Rule 10b5-1.
Billionaire Hedge Funds
